Weekly Shot Gets FDA Nod for Type 2 Diabetes
The FDA has given its nod to Bydureon, making it the first weekly treatment for type 2 diabetes, according to drug's manufacturer.
Click here to read the full story.
The content has been reported and it will be reviewed by a moderator.
